[ad_1] Acer Therapeutics (NASDAQ: ACER) has filed a New Drug Application (NDA) with the FDA for approval of EDSIVO (celiprolol) for the treatment of Ehlers-Danlos Vascular Syndrome (VEDS), a tissue condition connective …
Read More »
[ad_1] What happened Actions of Sangamo Therapeutics (Nasdaq: SGMO) have fallen to 24.7% today on large volumes. The company's actions are in response to a somewhat disappointing interim update for its zinc …
Read More »[ad_1] What happened Actions of Sangamo Therapeutics (NASDAQ: SGMO) fell 24.7% today on large volumes. The company's actions are in response to a somewhat disappointing interim update for its zinc finger nuclease …
Read More »
[ad_1] Shares of Sangamo Therapeutics Inc. fell 23% in very active trading on Wednesday morning after the company released the first results of a gene-editing trial for a rare metabolic disorder called …
Read More »
[ad_1] Based on FDA comments, Voyager Therapeutics (NASDAQ: VYGR) says it is maintaining its plan to submit a BLA seeking approval for VY-AADC gene therapy based on live data 2. He says …
Read More »